Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 8/20 | 0.58 |
| ▸ | KDR | P35968 | 3/20 | 0.57 |
| ▸ | ROCK2 | O75116 | 7/20 | 0.55 |
| ▸ | NAMPT | P43490 | 4/20 | 0.55 |
| ▸ | CDK1 | P06493 | 1/20 | 0.54 |
| ▸ | CDK2 | P24941 | 1/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7704101 | 0.97 | CHEK1 (0.57) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7701118 | 0.92 | KDR (0.61) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7704717 | 0.89 | KDR (0.55) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7002937 | 0.86 | CHEK1 (0.61) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7094822 | 0.86 | KDR (0.56) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7701651 | 0.86 | KDM4E (0.57) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL6998816 | 0.86 | GLA (0.55) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7705309 | 0.84 | KDR (0.69) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7698438 | 0.84 | LMNA (0.58) | CHEK1KDRROCK2NAMPTCDK1 | |
| SCHEMBL7696919 | 0.84 | HTR1A (0.54) | CHEK1KDRNAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6462036-B1 | INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-08 | — | — | US | disclosed |